Flutoprazepam Market Size, Share, and Industry Report [2031]
Flutoprazepam Market Size, Share, and Industry Report [2031]
Segments - Global Flutoprazepam Market by Diseases (Anxiety, insomnia, stomach ulcers, and others), End-users (Adult and Children), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028
Upcoming
| Report ID :HC-3859
| 4.4 Rating
| 62 Reviews
| 215 Pages
| Format :
Report Description
The global Flutoprazepam market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028.
Flutoprazepam is a benzodiazepine which is available in Japan. It shows hypnotic, anxiolytic, anticonvulsant and sedative effects. It is used for the treatment for stomach ulcers and severe insomnia. Flutoprazepam does not fall under the international Convention on Psychotropic Substances of 1971 and is currently unscheduled in the United States. Benzodiazepines act as central nervous system depressants by boosting the activities of the neurotransmitter gamma-aminobutyric acid (GABA) on the benzodiazepine site of the GABA type A (GABAA) receptor. Anxiolytic and sedative effects, muscular relaxation, and anticonvulsive activity are among their effects.
Flutoprazepam is currently unregulated in the United States because it does not fall under the 1971 International Convention on Psychotropic Substances. Flutoprazepam is classified as a Class C-Schedule II drug, according to the Misuse of Drugs Act, in Singapore and a Schedule III psychotic substance in Thailand. Flutoprazepam is regulated in Hong Kong under Schedule 1 of the Chapter 134 Dangerous Drugs Ordinance. Only health professionals and university researchers are allowed to use flutoprazepam legally. Pharmacists can dispense the drug with a prescription. A punishment of $10000 (HKD) might be imposed on anyone who supplies the substance without a prescription. A fine of $5,000,000 (HKD) and life imprisonment are the penalties for trafficking or manufacturing the chemical. Possession of the substance for human consumption without a Department of Health licence is prohibited by a penalty of $1,000,000 (HKD) and/or seven years in prison.
Market Trends, Drivers, Restraints, and Opportunities:
- Increasing demand for Flutoprazepam from the pharmaceutical industry increase in prevalence of anxiety, seizures, insomnia is fueling the market growth.
- Rise in concern for prevention of stress and related conditions is also driving the market.
- This drug is not regulated in many regions, which in turn, is expected to hamper the market growth.
Scope of the report:
The report on Flutoprazepam market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
| Attributes | Details |
| Report Title | Flutoprazepam Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | By Diseases (Anxiety, insomnia, stomach ulcers, and others), End-users (Adult and Children) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Cayman Chemical and DC Chemicals Ltd |
Flutoprazepam Market Segment Insights:
The Anxiety segment is projected to hold significant market share
In the terms of diseases, the Flutoprazepam market can be segmented into anxiety, insomnia, stomach ulcers, and others. Anxiety disorders segment is expected to hold a significant market share in the benzodiazepine drugs. According to the World Health Organization (WHO), the projected number of persons living with anxiety disorders worldwide is 264 million in 2015. This is a 14.9 percent increase since 2005, owing to population growth and ageing. Females are more likely than males to suffer from anxiety disorders (4.6 percent in females compared to 2.6 percent in males at the global level). In 2017, anxiety was a major section of the worldwide benzodiazepine medication market, and this trend is projected to continue during the forecast period.
Adults segment to grow during the forecast period
On the basis of end-users, the market can be bifurcated into adults and children. The adult segment is expected to hold a significant share of the market during the forecast period due to increase in geriatric population and rise of population suffering from stress.
Asia Pacific dominates the global market
In terms of regions, the global Flutoprazepam market can be split into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific constituted a significant share of the market in 2020 due to mergers and acquisitions conducted by key market players. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to growing prevalence of anxiety among population.
Segments
Diseases- Anxiety
- Insomnia
- Stomach ulcers
- Others
- Adults
- Children
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
- Cayman Chemical
- DC Chemicals Ltd
Competitive Landscape
Key players in the Flutoprazepam market include Cayman Chemical and DC Chemicals Ltd. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Flutoprazepam Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Flutoprazepam Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Flutoprazepam Market - Supply Chain
4.5. Global Flutoprazepam Market Forecast
4.5.1. Flutoprazepam Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Flutoprazepam Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Flutoprazepam Market Absolute $ Opportunity
5. Global Flutoprazepam Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Flutoprazepam Market Size and Volume Forecast by End Users
5.3.1. Adults
5.3.2. Children
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Flutoprazepam Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Flutoprazepam Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Flutoprazepam Demand Share Forecast, 2019-2026
7. North America Flutoprazepam Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Flutoprazepam Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Flutoprazepam Market Size and Volume Forecast by End Users
7.4.1. Adults
7.4.2. Children
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Flutoprazepam Demand Share Forecast, 2019-2026
8. Latin America Flutoprazepam Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Flutoprazepam Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Flutoprazepam Market Size and Volume Forecast by End Users
8.4.1. Adults
8.4.2. Children
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Flutoprazepam Demand Share Forecast, 2019-2026
9. Europe Flutoprazepam Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Flutoprazepam Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Flutoprazepam Market Size and Volume Forecast by End Users
9.4.1. Adults
9.4.2. Children
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Flutoprazepam Demand Share Forecast, 2019-2026
10. Asia Pacific Flutoprazepam Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Flutoprazepam Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Flutoprazepam Market Size and Volume Forecast by End Users
10.4.1. Adults
10.4.2. Children
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Flutoprazepam Demand Share Forecast, 2019-2026
11. Middle East & Africa Flutoprazepam Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Flutoprazepam Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Flutoprazepam Market Size and Volume Forecast by End Users
11.4.1. Adults
11.4.2. Children
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Flutoprazepam Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Flutoprazepam Market: Market Share Analysis
12.2. Flutoprazepam Distributors and Customers
12.3. Flutoprazepam Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Cayman Chemical
12.4.2. DC Chemicals Ltd
Methodology
Related Reports
Some other reports from this category!
Our Clients
